BSE filing, NSE: SANGAMIND. Summary written from the filing by ALFA Finder's alert engine.
Sangam (India) Ltd: key numbers
- Share price
- ₹600.70
- Market cap
- ₹3,018 Cr
- Revenue (annual)
- ₹3,235 Cr
- Net profit (annual)
- ₹82.60 Cr
- P/E (TTM)
- 24.8×Sector 49.0×
- Promoter holding
- 70.52%+0.00% QoQ
- FII holding
- 2.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sangam (India) Ltd
All →Sangam (India) Board Meeting Date
Sangam India Ltd scheduled its board meeting for 4 November 2026 to approve unaudited Q2 results. No financial figures or decisions are reported in this prior intimation.
Sangam (India) Credit Rating
India Ratings upgraded Sangam (India)'s bank loan facilities to IND A/Stable from IND A-. Fresh bank facilities were also assigned the same rating.
Sangam (India) Annual General Meeting
Sangam (India) Limited announced the successful completion of a postal ballot, approving the appointment of Mr. Ranjan Jagetia as an Independent Director.
Sangam (India) Other Announcement
Designated person Devendra Sukhwal sold 4,625 shares of Sangam India Ltd via market sale for ₹0.28 Crore.
- Value
- ₹0.28 Cr
Sangam (India) Acquisition Worth ₹4.76 Cr
Sangam (India) Limited acquired a 0.97% stake in CGE II Hybrid Energy Private Limited for ₹4.76 Crore to secure captive renewable energy for its Rajasthan plants.
- Value
- ₹4.76 Cr
- renewable power consumption
- 5.0 MW
Sangam (India) Adverse Business Impact
Sangam (India) Ltd reported a fire at its Spinning Division in Rajasthan. The estimated loss is Rs. 4 Crores, with insurance coverage initiated for affected assets.
- Value
- ₹4.00 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date